Morningstar Law Group is pleased to welcome Jennifer Ball to the firm’s FDA & Healthcare Regulatory practice area. Jenn will be based in our Raleigh office, where she brings to our clients a unique blend of legal acumen, scientific training, and deep in-house experience.
Jenn is a Raleigh attorney with a background in biology and a lifelong interest in innovation. She advises life sciences and healthcare companies on a range of regulatory and transactional matters, including licensing agreements, product development, and strategic growth initiatives. Known for her ability to simplify complex legal and technical issues, Jenn provides tailored, pragmatic counsel that aligns with each client’s goals and stage of development.
Her industry insight comes from years of in-house legal roles at leading life sciences and healthcare organizations — including Syngenta, where she worked on global R&D, licensing, and M&A matters, as well as leadership roles at a clinical research organization, a pharmaceutical manufacturer, a gene therapy company, and a metabolomics lab. This hands-on experience gives her a deep appreciation of how innovative companies operate and the regulatory challenges they face.
Jenn began her legal career in Delaware, advising business entities at one of the state’s largest firms, and later worked with North Carolina startups through a boutique practice focused on early-stage company formation, funding, and exit strategy.
We’re excited to have Jenn on board and know our clients will benefit from her thoughtful, business-minded approach to regulatory and transactional counsel.
